Haploidentical bone marrow transplantation without T-cell depletion

Seminars in Oncology

Volumn 39, Issue 6, 2012, Pages 653-663

  Chang, Ying Jun ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

BONE MARROW TRANSPLANTATION; CELL EXPANSION; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR LYMPHOCYTE INFUSION; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 84870671757     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.09.003     Document Type: Article

References (72)

1. F. Aversa, A. Tabilio, A. Terenzi Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 84 1994 3948 3955
2. L.M. Ball, M.E. Bernardo, H. Roelofs Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation Blood 110 2007 2764 2767
3. K.K. Ballen, J. Koreth, Y.B. Chen, B.R. Dey, T.R. Spitzer Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant Blood 119 2012 1972 1980
4. T. Klingebiel, J. Cornish, M. Labopin Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group Blood 115 2010 3437 3446
5. J.J. van Rood, F.R. Loberiza Jr, M.J. Zhang Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling Blood 99 2002 1572 1577
6. X.J. Huang, Y.J. Chang Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation Biol Blood Marrow Transplant 17 2011 197 204
7. X.J. Huang, D.H. Liu, K.Y. Liu Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation Biol Blood Marrow Transplant 15 2009 257 265
8. Y. Reisner, D. Hagin, M.F. Martelli Haploidentical hematopoietic transplantation: current status and future perspectives Blood 118 2011 6006 6017
9. K.H. Lee, J.H. Lee, D.Y. Kim Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome Blood 118 2011 2609 2617
10. Y.L. Kasamon, L. Luznik, M.S. Leffell Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome Biol Blood Marrow Transplant 16 2010 482 489
11. D. Grosso, M. Carabasi, J. Filicko-O'Hara A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing Blood 118 2011 4732 4739
12. X.J. Huang, D.H. Liu, K.Y. Liu Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transplant 38 2006 291 297
13. T. Ichinohe, T. Uchiyama, C. Shimazaki Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism Blood 104 2004 3821 3828
14. K. Ikegame, Y. Tanji, N. Kitai Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling Bone Marrow Transplant 31 2003 507 510
15. Y.J. Chang, L.P. Xu, D.H. Liu The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation Pediatr Blood Cancer 53 2009 1100 1106
16. Y.J. Chang, X.Y. Zhao, M.R. Huo Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies Medicine (Baltimore) 88 2009 322 330
17. Y.J. Chang, X.Y. Zhao, M.R. Huo Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation J Clin Immunol 32 2012 268 280
18. Y.J. Chang, X.Y. Zhao, M.R. Huo Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies Am J Hematol 86 2011 227 230
19. X.J. Huang, X.Y. Zhao, D.H. Liu, K.Y. Liu, L.P. Xu Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion Leukemia 21 2007 848 851
20. D.H. Liu, X.S. Zhao, Y.J. Chang The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation Pediatr Blood Cancer 57 2011 135 141
21. X.Y. Zhao, Y.J. Chang, L.P. Xu, D.H. Liu, K.Y. Liu, X.J. Huang Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors Bone Marrow Transplant 44 2009 721 728
22. X.Y. Zhao, X.J. Huang, K.Y. Liu, L.P. Xu, D.H. Liu Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome Biol Blood Marrow Transplant 13 2007 734 744
23. R.A. Brodsky, L. Luznik, J. Bolanos-Meade, M.S. Leffell, R.J. Jones, E.J. Fuchs Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases Bone Marrow Transplant 42 2008 523 527
24. P. Sodani, A. Isgro, J. Gaziev Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia Blood 115 2010 1296 1302
25. Q.F. Liu, X.J. Xu, Y.K. Chen Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China Ann Hematol 90 2011 331 341
26. Y.L. Kasamon, L. Luznik, M.S. Leffell Significance of missing Inhibitory KIR ligands in nonmyeloablative, HLA-haploidentical (Haplo) BMT with posttransplantation high-dose cyclophosphamide (PT/Cy) Blood 118 2011 abstract 840
27. F. Aversa Setting the standard in T-cell-depleted haploidentical transplantation and beyond Best Pract Res Clin Haematol 24 2011 325 329
28. F. Aversa, A. Terenzi, A. Tabilio Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 2005 3447 3454
29. W. Huang, H. Li, C. Gao Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies Transfusion 52 2012 1354 1362
30. S. Tuve, J. Gayoso, C. Scheid Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy Leukemia 25 2011 880 883
31. A.T. Munchel, Y.L. Kasamon, E.J. Fuchs Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide Best Pract Res Clin Haematol 24 2011 359 368
32. Y. Kang, N.J. Chao, F. Aversa Unmanipulated or CD34 selected haplotype mismatched transplants Curr Opin Hematol 15 2008 561 567
33. K. Kaida, K. Ikegame, S. Yoshihara Unmanipulated hla-haploidentical (2-3 antigenmismatched) stem cell transplantation using myeloablative or reduced-intensity preconditioning regimen Blood 118 2011 abstract 4117
34. X.J. Huang Long term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro t cell depletion for the treatment of hematological malignancies: 9-year experience of a single center Blood 118 2011 abstract 839
35. H. Muramatsu, H. Yabe, R. Kobayashi Allogeneic bone marrow transplantation from hla mismatched family donors in children with aplastic anemia Blood 11 2011 abstract 831
36. H. Sano, S. Kobayashi, M. Akaihata Non-T-cell depleted hla haploidentical hematopoietc stem cell transplantation for refractory or relapsed pediatric solid tumor Blood 118 2011 abstract 4470
37. H.J. Symons, C. Kesserwan, F. Kos Favorable immune reconstitution after nonmyeloablative, T-cell replete, HLA-haploidentical bmt with post-transplant cyclophosphamide Blood 118 2011 abstract 1009
38. I.G.G. Marin, A.M. Perez-Corral, J. Gayoso Natural killer (NK) cell reconstitution after haploidentical unmanipulated bone marrow transplantation with reduced intensity conditioning Blood 118 2011 abstract 4557
39. Y.J. Chang, X.Y. Zhao, X.J. Huang Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies Biol Blood Marrow Transplant 14 2008 323 334
40. Y.W. Fu, P. Wu de, J.N. Cen Patterns of T-cell reconstitution by assessment of T-cell receptor excision circle and T-cell receptor clonal repertoire after allogeneic hematopoietic stem cell transplantation in leukemia patients - a study in Chinese patients Eur J Haematol 79 2007 138 145
41. S.Y. Lu, K.Y. Liu, D.H. Liu, L.P. Xu, X.J. Huang High frequencies of CD62L naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation Clin Exp Immunol 165 2011 264 277
42. X.H. Luo, Y.J. Chang, L.P. Xu, D.H. Liu, K.Y. Liu, X.J. Huang The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/ haploidentical hematopoietic SCT Bone Marrow Transplant 43 2009 29 36
43. Y.J. Chang, L.P. Xu, D.H. Liu Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status Biol Blood Marrow Transplant 15 2009 632 638
44. Y.J. Chang, X.Y. Zhao, M.R. Huo, X.J. Huang Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation J Clin Immunol 29 2009 696 704
45. M.R. Huo, L.P. Xu, D. Li The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation Clin Transplant 26 2012 284 291
46. M. Geddes, J. Storek Immune reconstitution following hematopoietic stem-cell transplantation Best Pract Res Clin Haematol 20 2007 329 348
47. X.Y. Zhao, Y.J. Chang, X.J. Huang Conflicting impact of alloreactive NK cells on transplantation outcomes after haploidentical transplantation: do the reconstitution kinetics of natural killer cells create these differences? Biol Blood Marrow Transplant 17 2011 1436 1442
48. L. Ruggeri, F. Aversa, M.F. Martelli, A. Velardi Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self Immunol Rev 214 2006 202 218
49. D.P. Lu, L. Dong, T. Wu Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation Blood 107 2006 3065 3073
50. Y. Wang, D.H. Liu, L.P. Xu Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison Biol Blood Marrow Transplant 17 2011 821 830
51. H. Xiao-Jun, X. Lan-Ping, L. Kai-Yan Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies Clin Cancer Res 15 2009 4777 4783
52. D. Valcarcel, J. Sierra, T. Wang One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing Biol Blood Marrow Transplant 17 2011 640 648
53. P.J. Shaw, F. Kan, K. Woo Ahn Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors Blood 116 2010 4007 4015
54. C.G. Brunstein, E.J. Fuchs, S.L. Carter Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts Blood 118 2011 282 288
55. S.O. Ciurea, R.M. Saliba, U.D. Bayraktar Improved early outcomes with T-cell replete (TCR) compared with T-cell depleted (TCD) haploidentical stem cell transplantation (HaploSCT) Blood 118 2011 abstract 320
56. H.M. Lazarus, O.N. Koc, S.M. Devine Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients Biol Blood Marrow Transplant 11 2005 389 398
57. K. Liu, Y. Chen, Y. Zeng Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study Stem Cells Dev 20 2011 1679 1685
58. X.J. Huang, D.H. Liu, K.Y. Liu Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia J Clin Immunol 28 2008 276 283
59. X.J. Huang, D.H. Liu, K.Y. Liu, L.P. Xu, H. Chen, W. Han Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/ haploidentical T-cell-replete hematopoietic stem cell transplantation Haematologica 92 2007 414 417
60. Y. Wang, D.H. Liu, L.P. Xu Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis Bone Marrow Transplant 47 2012 1099 1104
61. T.J. Boeld, K. Doser, C. Lang-Schwarz Efficient treatment of murine acute graft-versus-host disease with in vitro expanded CD4+CD25+ regulatory T cells Blood 118 2011 abstract 2987
62. M. Di Ianni, F. Falzetti, A. Carotti Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation Blood 117 2011 3921 3928
63. C.G. Brunstein, J.S. Miller, Q. Cao Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics Blood 117 2011 1061 1070
64. K.Y. Liu, Y.H. Chen, D.H. Liu, L.P. Xu, X.J. Huang A pilot study of low-dose recombinant interleukin-2 for acute lymphoblastic malignancy after unmanipulated allogeneic blood and marrow transplantation Bone Marrow Transplant 42 2008 535 539
65. P. Schlegel, H.M. Teltschik, M. Pfeiffer Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children Best Pract Res Clin Haematol 24 2011 443 452
66. X.H. Luo, X.J. Huang, K.Y. Liu, L.P. Xu, D.H. Liu Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 16 2010 994 1004
67. T. Feuchtinger, K. Opherk, W.A. Bethge Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation Blood 116 2010 4360 4367
68. R. Seggewiss, H. Einsele Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update Blood 115 2010 3861 3868
69. J. Kanda, H. Saji, T. Fukuda Related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction and HLA 8/8-allele-matched unrelated transplantation: a nationwide retrospective study Blood 119 2012 2409 2416
70. H.J. Symons, A.R. Chen, L. Luznik Myeloablative haploidentical bone marrow transplantation with T cell replete grafts and post-transplant cyclophosphamide: results of a phase II clinical trial Blood 118 2011 abstract 4151
71. C.A. Sizemore, A. Bashey, M. Sanacore Haploidentical transplantation using T-cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial Blood 118 2011 abstract 889
72. S. Santarone, G. De Angelis, E. Di Bartolomeo Non T-depleted bone marrow transplantation from haploidentical related donor in hematological malignancies Blood 118 2011 abstract 2291